| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Medicine and AIDS Institute, Center for Health Sciences, University of California, Los Angeles, CA 90095;
Department of Medicine, University of California San Diego, La Jolla, CA 92093; and
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109
Nef is an HIV-1 protein that is absent in most retroviruses, yet its reading frame is highly maintained despite frequent targeting by CD8+ CTL in vivo. Because Nef is not necessarily required for viral replication, this consistent maintenance suggests that Nef plays an important role(s) and substantial fitness constraints prevent its loss in vivo. The ability of Nef to down-regulate cell surface MHC class I (MHC-I) molecules and render infected cells resistant to CTL in general is likely to be an important contributing function. We demonstrate that mutational escape of HIV-1 from Nef-specific CTL in vitro leads to progeny virions that are increased in their susceptibility to CTL of specificities for proteins other than Nef. The escape mutants contain multiple nef mutations that impair the ability of the virus to down-regulate MHC-I through disruption of its reading frame as well as epitope point mutations. Given the rarity of nef frameshifts in vivo, these data support the concept that the ability to down-regulate MHC-I could be a key constraint for preservation of Nef in vivo.
This article has been cited by other articles:
|
|
 |
|
  N. J. Maness, L. J. Yant, C. Chung, J. T. Loffredo, T. C. Friedrich, S. M. Piaskowski, J. Furlott, G. E. May, T. Soma, E. J. Leon, et al. Comprehensive Immunological Evaluation Reveals Surprisingly Few Differences between Elite Controller and Progressor Mamu-B*17-Positive Simian Immunodeficiency Virus-Infected Rhesus Macaques J. Virol., June 1, 2008; 82(11): 5245 - 5254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Lewis, A. Balamurugan, A. Ohno, S. Kilpatrick, H. L. Ng, and O. O. Yang Functional Adaptation of Nef to the Immune Milieu of HIV-1 Infection In Vivo J. Immunol., March 15, 2008; 180(6): 4075 - 4081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ueno, C. Motozono, S. Dohki, P. Mwimanzi, S. Rauch, O. T. Fackler, S. Oka, and M. Takiguchi CTL-Mediated Selective Pressure Influences Dynamic Evolution and Pathogenic Functions of HIV-1 Nef J. Immunol., January 15, 2008; 180(2): 1107 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Noviello, S. L. K. Pond, M. J. Lewis, D. D. Richman, S. K. Pillai, O. O. Yang, S. J. Little, D. M. Smith, and J. C. Guatelli Maintenance of Nef-Mediated Modulation of Major Histocompatibility Complex Class I and CD4 after Sexual Transmission of Human Immunodeficiency Virus Type 1 J. Virol., May 1, 2007; 81(9): 4776 - 4786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Adnan, A. Balamurugan, A. Trocha, M. S. Bennett, H. L. Ng, A. Ali, C. Brander, and O. O. Yang Nef interference with HIV-1-specific CTL antiviral activity is epitope specific Blood, November 15, 2006; 108(10): 3414 - 3419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kan-Mitchell, M. Bajcz, K. L. Schaubert, D. A. Price, J. M. Brenchley, T. E. Asher, D. C. Douek, H. L. Ng, O. O. Yang, C. R. Rinaldo Jr., et al. Degeneracy and Repertoire of the Human HIV-1 Gag p1777-85 CTL Response. J. Immunol., June 1, 2006; 176(11): 6690 - 6701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Geels, S. A. Dubey, K. Anderson, E. Baan, M. Bakker, G. Pollakis, W. A. Paxton, J. W. Shiver, and J. Goudsmit Broad Cross-Clade T-Cell Responses to Gag in Individuals Infected with Human Immunodeficiency Virus Type 1 Non-B Clades (A to G): Importance of HLA Anchor Residue Conservation J. Virol., September 1, 2005; 79(17): 11247 - 11258. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
